data_2b8g_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2b8g _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 23.5 m . . . . . 0 N--CA 1.469 0.52 0 CA-C-O 117.141 -1.409 . . . . 10.0 113.285 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.2 t -82.52 146.99 6.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 104.054 -2.572 . . . . 10.0 104.054 174.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 45.4 m -142.55 161.0 39.19 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.98 1.312 . . . . 10.0 108.266 -175.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.404 HG21 ' H ' ' A' ' 7' ' ' MET . 4.4 mm -72.94 156.27 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 124.906 1.282 . . . . 10.0 107.733 173.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.67 5.19 6.12 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.814 1.245 . . . . 10.0 112.154 -171.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.404 ' H ' HG21 ' A' ' 5' ' ' ILE . 3.5 tpt -156.99 149.89 23.69 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 107.89 -1.152 . . . . 10.0 107.89 -173.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.4 133.7 51.91 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.65 0.78 . . . . 10.0 109.009 172.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.36 -161.24 32.02 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-N 118.945 0.793 . . . . 10.0 112.613 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -135.58 133.5 38.38 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 105.61 -1.996 . . . . 10.0 105.61 -176.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 12.5 tp -79.63 67.46 5.4 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.488 0.715 . . . . 10.0 110.561 -167.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.7 t90 -36.72 -48.45 0.72 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 129.272 3.029 . . . . 10.0 113.221 -174.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -141.46 157.96 44.48 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 119.088 0.858 . . . . 10.0 110.17 174.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 93.7 t -133.24 146.61 32.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 106.075 -1.824 . . . . 10.0 106.075 174.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -135.1 21.94 3.48 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.092 0.957 . . . . 10.0 110.98 -168.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.1 m -136.11 156.15 36.31 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 C-N-CA 125.173 1.389 . . . . 10.0 108.021 -174.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -143.98 159.77 42.0 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.651 -1.24 . . . . 10.0 107.651 174.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.28 134.04 23.29 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.423 -0.584 . . . . 10.0 109.423 166.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.05 -7.8 73.36 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.666 1.603 . . . . 10.0 114.444 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -77.81 154.12 32.17 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.567 1.684 . . . . 10.0 110.795 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.2 tp60 -94.66 140.54 29.74 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 106.612 -1.625 . . . . 10.0 106.612 178.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.9 pt -132.51 164.93 33.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 109.089 -0.708 . . . . 10.0 109.089 171.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -140.46 142.53 35.33 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.962 1.705 . . . . 10.0 106.406 -174.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.526 ' HE2' ' O ' ' A' ' 43' ' ' ASP . 5.9 ttmt -52.95 123.8 12.51 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.301 0.64 . . . . 10.0 110.473 -176.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.04 -8.3 76.07 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-O 118.882 -0.955 . . . . 10.0 113.421 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.45 138.87 53.83 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 118.982 1.391 . . . . 10.0 108.328 172.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -64.08 127.51 31.75 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.59 1.156 . . . . 10.0 108.334 173.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.4 m -121.3 -23.59 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.17 0.988 . . . . 10.0 110.843 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.54 177.7 10.94 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.424 1.089 . . . . 10.0 109.573 171.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.7 mt -138.93 138.84 41.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 105.903 -1.888 . . . . 10.0 105.903 173.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 78.8 mt -93.21 131.09 38.62 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.257 1.023 . . . . 10.0 109.1 166.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.89 142.99 47.91 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 105.314 -2.106 . . . . 10.0 105.314 135.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.6 m -139.97 79.02 1.69 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.304 -1.369 . . . . 10.0 107.304 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 56.42 41.6 28.66 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.202 1.401 . . . . 10.0 109.861 175.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.8 mttm 88.68 7.86 0.14 Allowed 'General case' 0 C--N 1.349 0.551 0 C-N-CA 129.337 3.055 . . . . 10.0 114.059 178.281 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 69.1 mtm -98.37 165.49 11.83 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.127 0.971 . . . . 10.0 108.434 166.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -126.1 132.0 51.99 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.158 1.383 . . . . 10.0 108.104 -175.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 15.1 mt -144.96 110.41 4.74 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 107.133 -1.432 . . . . 10.0 107.133 -175.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -57.25 149.28 65.31 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.427 2.085 . . . . 10.0 110.721 170.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 17.2 mm -124.4 116.1 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 N-CA-C 104.107 -2.553 . . . . 10.0 104.107 174.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.2 m -112.75 155.56 13.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.295 -1.002 . . . . 10.0 108.295 -174.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.62 119.92 11.42 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 123.95 0.9 . . . . 10.0 109.17 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.526 ' O ' ' HE2' ' A' ' 24' ' ' LYS . 23.1 t70 -61.01 -22.06 64.17 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.977 0.911 . . . . 10.0 111.783 172.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -159.03 163.84 36.0 Favored 'General case' 0 C--O 1.232 0.172 0 O-C-N 120.13 -1.606 . . . . 10.0 110.633 177.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.2 m -78.84 150.57 32.24 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.813 -1.085 . . . . 10.0 110.154 173.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.95 -178.35 40.67 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.565 -0.614 . . . . 10.0 111.565 175.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -97.63 133.85 37.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 104.816 -2.29 . . . . 10.0 104.816 169.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 89.6 t -66.18 125.49 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 C-N-CA 124.789 1.236 . . . . 10.0 107.815 174.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 47.1 tttt -85.71 -47.35 9.86 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.105 -0.952 . . . . 10.0 109.918 167.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -153.32 155.6 36.8 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.42 -0.585 . . . . 10.0 109.42 -175.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.5 t -114.74 119.44 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 105.321 -2.103 . . . . 10.0 105.321 171.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -82.82 -3.42 56.72 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.8 1.24 . . . . 10.0 112.357 -172.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -145.89 178.32 8.27 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.612 1.965 . . . . 10.0 106.949 -178.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.0 pttt -145.71 173.21 12.28 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.754 -1.202 . . . . 10.0 107.754 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -41.89 124.42 2.62 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 126.13 1.772 . . . . 10.0 110.746 168.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.26 4.07 88.79 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 118.103 -1.387 . . . . 10.0 113.663 170.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -74.28 149.6 40.63 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 119.4 1.6 . . . . 10.0 110.366 175.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -76.39 142.98 40.95 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 122.348 1.071 . . . . 10.0 109.122 175.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -147.66 160.97 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 121.792 0.806 . . . . 10.0 110.928 -173.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -150.01 169.82 20.31 Favored 'General case' 0 CA--C 1.516 -0.333 0 O-C-N 120.692 -1.255 . . . . 10.0 111.907 -176.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -56.73 123.49 15.14 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.719 -0.845 . . . . 10.0 108.719 175.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.94 -6.39 81.21 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-O 118.716 -1.047 . . . . 10.0 114.1 177.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -72.49 135.65 45.73 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 118.573 1.187 . . . . 10.0 107.871 175.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.8 m -65.72 157.76 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 122.721 1.248 . . . . 10.0 111.402 -174.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.6 tp -133.35 -44.09 0.84 Allowed 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 124.446 1.098 . . . . 10.0 110.015 177.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.12 146.72 30.02 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.75 -0.833 . . . . 10.0 108.75 -162.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -127.39 141.52 51.67 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 105.804 -1.924 . . . . 10.0 105.804 168.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 11.6 mt -130.04 143.13 50.62 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.749 -1.204 . . . . 10.0 107.749 -171.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.0 m -72.33 -7.76 51.32 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 126.347 1.859 . . . . 10.0 111.11 173.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -125.88 50.36 1.86 Allowed 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 127.101 2.161 . . . . 10.0 110.733 173.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 42.2 m -135.47 6.68 3.27 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 127.072 2.149 . . . . 10.0 112.665 164.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.96 -29.07 11.64 Favored 'General case' 0 CA--C 1.55 0.971 1 C-N-CA 133.122 4.569 . . . . 10.0 108.452 -150.063 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 . . . . . 0 C--O 1.245 0.857 0 C-N-CA 128.562 2.745 . . . . 10.0 110.648 124.854 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' BTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.586 HG21 ' OG ' ' A' ' 71' ' ' SER . 23.5 m . . . . . 0 N--CA 1.469 0.52 0 CA-C-O 117.141 -1.409 . . . . 10.0 113.285 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.2 t -82.52 146.99 6.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 104.054 -2.572 . . . . 10.0 104.054 174.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 45.4 m -142.55 161.0 39.19 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.98 1.312 . . . . 10.0 108.266 -175.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.457 HG22 ' H ' ' A' ' 7' ' ' MET . 4.4 mm -72.94 156.27 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 124.906 1.282 . . . . 10.0 107.733 173.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.67 5.19 6.12 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.814 1.245 . . . . 10.0 112.154 -171.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.457 ' H ' HG22 ' A' ' 5' ' ' ILE . 3.5 tpt -156.99 149.89 23.69 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 107.89 -1.152 . . . . 10.0 107.89 -173.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -65.4 133.7 51.91 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.65 0.78 . . . . 10.0 109.009 172.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.36 -161.24 32.02 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-N 118.945 0.793 . . . . 10.0 112.613 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -135.58 133.5 38.38 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 105.61 -1.996 . . . . 10.0 105.61 -176.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 12.5 tp -79.63 67.46 5.4 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.488 0.715 . . . . 10.0 110.561 -167.213 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.7 t90 -36.72 -48.45 0.72 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 129.272 3.029 . . . . 10.0 113.221 -174.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -141.46 157.96 44.48 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 119.088 0.858 . . . . 10.0 110.17 174.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 93.7 t -133.24 146.61 32.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 106.075 -1.824 . . . . 10.0 106.075 174.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -135.1 21.94 3.48 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.092 0.957 . . . . 10.0 110.98 -168.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.633 HG21 HD11 ' A' ' 66' ' ' LEU . 2.1 m -136.11 156.15 36.31 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 C-N-CA 125.173 1.389 . . . . 10.0 108.021 -174.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -143.98 159.77 42.0 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.651 -1.24 . . . . 10.0 107.651 174.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.28 134.04 23.29 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.423 -0.584 . . . . 10.0 109.423 166.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.05 -7.8 73.36 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.666 1.603 . . . . 10.0 114.444 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -77.81 154.12 32.17 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.567 1.684 . . . . 10.0 110.795 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.2 tp60 -94.66 140.54 29.74 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 106.612 -1.625 . . . . 10.0 106.612 178.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.9 pt -132.51 164.93 33.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 109.089 -0.708 . . . . 10.0 109.089 171.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -140.46 142.53 35.33 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.962 1.705 . . . . 10.0 106.406 -174.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.586 ' HE2' ' O ' ' A' ' 43' ' ' ASP . 5.9 ttmt -52.95 123.8 12.51 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.301 0.64 . . . . 10.0 110.473 -176.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.04 -8.3 76.07 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-O 118.882 -0.955 . . . . 10.0 113.421 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.45 138.87 53.83 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 118.982 1.391 . . . . 10.0 108.328 172.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -64.08 127.51 31.75 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.59 1.156 . . . . 10.0 108.334 173.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.4 m -121.3 -23.59 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.17 0.988 . . . . 10.0 110.843 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.54 177.7 10.94 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.424 1.089 . . . . 10.0 109.573 171.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.7 mt -138.93 138.84 41.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 105.903 -1.888 . . . . 10.0 105.903 173.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 78.8 mt -93.21 131.09 38.62 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.257 1.023 . . . . 10.0 109.1 166.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.89 142.99 47.91 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 105.314 -2.106 . . . . 10.0 105.314 135.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.6 m -139.97 79.02 1.69 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.304 -1.369 . . . . 10.0 107.304 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 56.42 41.6 28.66 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.202 1.401 . . . . 10.0 109.861 175.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.8 mttm 88.68 7.86 0.14 Allowed 'General case' 0 C--N 1.349 0.551 0 C-N-CA 129.337 3.055 . . . . 10.0 114.059 178.281 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 69.1 mtm -98.37 165.49 11.83 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.127 0.971 . . . . 10.0 108.434 166.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -126.1 132.0 51.99 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.158 1.383 . . . . 10.0 108.104 -175.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 15.1 mt -144.96 110.41 4.74 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 107.133 -1.432 . . . . 10.0 107.133 -175.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -57.25 149.28 65.31 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.427 2.085 . . . . 10.0 110.721 170.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 17.2 mm -124.4 116.1 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 N-CA-C 104.107 -2.553 . . . . 10.0 104.107 174.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.2 m -112.75 155.56 13.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.295 -1.002 . . . . 10.0 108.295 -174.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.62 119.92 11.42 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 123.95 0.9 . . . . 10.0 109.17 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.586 ' O ' ' HE2' ' A' ' 24' ' ' LYS . 23.1 t70 -61.01 -22.06 64.17 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.977 0.911 . . . . 10.0 111.783 172.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -159.03 163.84 36.0 Favored 'General case' 0 C--O 1.232 0.172 0 O-C-N 120.13 -1.606 . . . . 10.0 110.633 177.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.2 m -78.84 150.57 32.24 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.813 -1.085 . . . . 10.0 110.154 173.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.95 -178.35 40.67 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.565 -0.614 . . . . 10.0 111.565 175.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -97.63 133.85 37.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 104.816 -2.29 . . . . 10.0 104.816 169.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.42 HG13 ' CD2' ' A' ' 66' ' ' LEU . 89.6 t -66.18 125.49 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 C-N-CA 124.789 1.236 . . . . 10.0 107.815 174.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 47.1 tttt -85.71 -47.35 9.86 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.105 -0.952 . . . . 10.0 109.918 167.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -153.32 155.6 36.8 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.42 -0.585 . . . . 10.0 109.42 -175.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.5 t -114.74 119.44 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 105.321 -2.103 . . . . 10.0 105.321 171.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.416 ' HE2' ' HB2' ' A' ' 67' ' ' GLU . 73.8 mmtt -82.82 -3.42 56.72 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.8 1.24 . . . . 10.0 112.357 -172.038 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -145.89 178.32 8.27 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.612 1.965 . . . . 10.0 106.949 -178.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.0 pttt -145.71 173.21 12.28 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.754 -1.202 . . . . 10.0 107.754 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -41.89 124.42 2.62 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 126.13 1.772 . . . . 10.0 110.746 168.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.26 4.07 88.79 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 118.103 -1.387 . . . . 10.0 113.663 170.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -74.28 149.6 40.63 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 119.4 1.6 . . . . 10.0 110.366 175.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -76.39 142.98 40.95 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 122.348 1.071 . . . . 10.0 109.122 175.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -147.66 160.97 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 121.792 0.806 . . . . 10.0 110.928 -173.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.406 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -150.01 169.82 20.31 Favored 'General case' 0 CA--C 1.516 -0.333 0 O-C-N 120.692 -1.255 . . . . 10.0 111.907 -176.186 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -56.73 123.49 15.14 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.719 -0.845 . . . . 10.0 108.719 175.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.94 -6.39 81.21 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-O 118.716 -1.047 . . . . 10.0 114.1 177.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -72.49 135.65 45.73 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 118.573 1.187 . . . . 10.0 107.871 175.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.8 m -65.72 157.76 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 122.721 1.248 . . . . 10.0 111.402 -174.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.6 tp -133.35 -44.09 0.84 Allowed 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 124.446 1.098 . . . . 10.0 110.015 177.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.633 HD11 HG21 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -147.12 146.72 30.02 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.75 -0.833 . . . . 10.0 108.75 -162.343 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.416 ' HB2' ' HE2' ' A' ' 52' ' ' LYS . 32.6 tt0 -127.39 141.52 51.67 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 105.804 -1.924 . . . . 10.0 105.804 168.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.406 HD21 HD22 ' A' ' 66' ' ' LEU . 11.6 mt -130.04 143.13 50.62 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.749 -1.204 . . . . 10.0 107.749 -171.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.0 m -72.33 -7.76 51.32 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 126.347 1.859 . . . . 10.0 111.11 173.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -125.88 50.36 1.86 Allowed 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 127.101 2.161 . . . . 10.0 110.733 173.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.586 ' OG ' HG21 ' A' ' 2' ' ' THR . 42.2 m -135.47 6.68 3.27 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 127.072 2.149 . . . . 10.0 112.665 164.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.96 -29.07 11.64 Favored 'General case' 0 CA--C 1.55 0.971 1 C-N-CA 133.122 4.569 . . . . 10.0 108.452 -150.063 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 . . . . . 0 C--O 1.245 0.857 0 C-N-CA 128.562 2.745 . . . . 10.0 110.648 124.854 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 135' ' ' BTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.586 HG21 ' OG ' ' A' ' 71' ' ' SER . 23.5 m . . . . . 0 N--CA 1.469 0.52 0 CA-C-O 117.141 -1.409 . . . . 10.0 113.285 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.2 t -82.52 146.99 6.33 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 N-CA-C 104.054 -2.572 . . . . 10.0 104.054 174.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 45.4 m -142.55 161.0 39.19 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.98 1.312 . . . . 10.0 108.266 -175.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.457 HG22 ' H ' ' A' ' 7' ' ' MET . 4.4 mm -72.94 156.27 6.82 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.703 0 C-N-CA 124.906 1.282 . . . . 10.0 107.733 173.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.67 5.19 6.12 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.814 1.245 . . . . 10.0 112.154 -171.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.457 ' H ' HG22 ' A' ' 5' ' ' ILE . 3.5 tpt -156.99 149.89 23.69 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 107.89 -1.152 . . . . 10.0 107.89 -173.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -65.4 133.7 51.91 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 123.65 0.78 . . . . 10.0 109.009 172.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.36 -161.24 32.02 Favored Glycine 0 C--N 1.336 0.551 0 CA-C-N 118.945 0.793 . . . . 10.0 112.613 -178.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -135.58 133.5 38.38 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 105.61 -1.996 . . . . 10.0 105.61 -176.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 12.5 tp -79.63 67.46 5.4 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.488 0.715 . . . . 10.0 110.561 -167.213 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.7 t90 -36.72 -48.45 0.72 Allowed 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 129.272 3.029 . . . . 10.0 113.221 -174.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.3 mtmt -141.46 157.96 44.48 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 119.088 0.858 . . . . 10.0 110.17 174.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 93.7 t -133.24 146.61 32.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 106.075 -1.824 . . . . 10.0 106.075 174.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -135.1 21.94 3.48 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.092 0.957 . . . . 10.0 110.98 -168.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.633 HG21 HD11 ' A' ' 66' ' ' LEU . 2.1 m -136.11 156.15 36.31 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.392 0 C-N-CA 125.173 1.389 . . . . 10.0 108.021 -174.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -143.98 159.77 42.0 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 107.651 -1.24 . . . . 10.0 107.651 174.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -50.28 134.04 23.29 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 109.423 -0.584 . . . . 10.0 109.423 166.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.05 -7.8 73.36 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.666 1.603 . . . . 10.0 114.444 178.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.1 t0 -77.81 154.12 32.17 Favored 'General case' 0 CA--C 1.532 0.275 0 CA-C-N 119.567 1.684 . . . . 10.0 110.795 179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 47.2 tp60 -94.66 140.54 29.74 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 106.612 -1.625 . . . . 10.0 106.612 178.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.9 pt -132.51 164.93 33.68 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 N-CA-C 109.089 -0.708 . . . . 10.0 109.089 171.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -140.46 142.53 35.33 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 125.962 1.705 . . . . 10.0 106.406 -174.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.586 ' HE2' ' O ' ' A' ' 43' ' ' ASP . 5.9 ttmt -52.95 123.8 12.51 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.301 0.64 . . . . 10.0 110.473 -176.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 93.04 -8.3 76.07 Favored Glycine 0 CA--C 1.535 1.321 0 CA-C-O 118.882 -0.955 . . . . 10.0 113.421 179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.45 138.87 53.83 Favored 'General case' 0 C--N 1.343 0.304 0 CA-C-N 118.982 1.391 . . . . 10.0 108.328 172.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -64.08 127.51 31.75 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 124.59 1.156 . . . . 10.0 108.334 173.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.4 m -121.3 -23.59 3.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.17 0.988 . . . . 10.0 110.843 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.54 177.7 10.94 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.424 1.089 . . . . 10.0 109.573 171.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 55.7 mt -138.93 138.84 41.43 Favored 'Isoleucine or valine' 0 C--O 1.235 0.328 0 N-CA-C 105.903 -1.888 . . . . 10.0 105.903 173.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 78.8 mt -93.21 131.09 38.62 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.257 1.023 . . . . 10.0 109.1 166.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.89 142.99 47.91 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 105.314 -2.106 . . . . 10.0 105.314 135.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 16.6 m -139.97 79.02 1.69 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 107.304 -1.369 . . . . 10.0 107.304 177.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 56.42 41.6 28.66 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.202 1.401 . . . . 10.0 109.861 175.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 38.8 mttm 88.68 7.86 0.14 Allowed 'General case' 0 C--N 1.349 0.551 0 C-N-CA 129.337 3.055 . . . . 10.0 114.059 178.281 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 69.1 mtm -98.37 165.49 11.83 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.127 0.971 . . . . 10.0 108.434 166.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -126.1 132.0 51.99 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 125.158 1.383 . . . . 10.0 108.104 -175.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 15.1 mt -144.96 110.41 4.74 Favored Pre-proline 0 CA--C 1.536 0.427 0 N-CA-C 107.133 -1.432 . . . . 10.0 107.133 -175.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -57.25 149.28 65.31 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 122.427 2.085 . . . . 10.0 110.721 170.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 17.2 mm -124.4 116.1 46.62 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 N-CA-C 104.107 -2.553 . . . . 10.0 104.107 174.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.2 m -112.75 155.56 13.96 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 108.295 -1.002 . . . . 10.0 108.295 -174.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -64.62 119.92 11.42 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 123.95 0.9 . . . . 10.0 109.17 -178.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.586 ' O ' ' HE2' ' A' ' 24' ' ' LYS . 23.1 t70 -61.01 -22.06 64.17 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.977 0.911 . . . . 10.0 111.783 172.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -159.03 163.84 36.0 Favored 'General case' 0 C--O 1.232 0.172 0 O-C-N 120.13 -1.606 . . . . 10.0 110.633 177.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.2 m -78.84 150.57 32.24 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 114.813 -1.085 . . . . 10.0 110.154 173.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 165.95 -178.35 40.67 Favored Glycine 0 N--CA 1.444 -0.802 0 N-CA-C 111.565 -0.614 . . . . 10.0 111.565 175.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -97.63 133.85 37.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 104.816 -2.29 . . . . 10.0 104.816 169.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.42 HG13 ' CD2' ' A' ' 66' ' ' LEU . 89.6 t -66.18 125.49 23.5 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 C-N-CA 124.789 1.236 . . . . 10.0 107.815 174.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 47.1 tttt -85.71 -47.35 9.86 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.105 -0.952 . . . . 10.0 109.918 167.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -153.32 155.6 36.8 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 109.42 -0.585 . . . . 10.0 109.42 -175.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.5 t -114.74 119.44 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 N-CA-C 105.321 -2.103 . . . . 10.0 105.321 171.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.416 ' HE2' ' HB2' ' A' ' 67' ' ' GLU . 73.8 mmtt -82.82 -3.42 56.72 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.8 1.24 . . . . 10.0 112.357 -172.038 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.5 mmtt -145.89 178.32 8.27 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.612 1.965 . . . . 10.0 106.949 -178.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 19.0 pttt -145.71 173.21 12.28 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 107.754 -1.202 . . . . 10.0 107.754 178.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -41.89 124.42 2.62 Favored 'General case' 0 C--N 1.322 -0.622 0 C-N-CA 126.13 1.772 . . . . 10.0 110.746 168.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 79.26 4.07 88.79 Favored Glycine 0 CA--C 1.528 0.874 0 CA-C-O 118.103 -1.387 . . . . 10.0 113.663 170.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -74.28 149.6 40.63 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-N 119.4 1.6 . . . . 10.0 110.366 175.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 86.6 t80 -76.39 142.98 40.95 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 122.348 1.071 . . . . 10.0 109.122 175.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -147.66 160.97 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 CA-C-O 121.792 0.806 . . . . 10.0 110.928 -173.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.406 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -150.01 169.82 20.31 Favored 'General case' 0 CA--C 1.516 -0.333 0 O-C-N 120.692 -1.255 . . . . 10.0 111.907 -176.186 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -56.73 123.49 15.14 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 108.719 -0.845 . . . . 10.0 108.719 175.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.94 -6.39 81.21 Favored Glycine 0 CA--C 1.534 1.22 0 CA-C-O 118.716 -1.047 . . . . 10.0 114.1 177.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 45.4 t0 -72.49 135.65 45.73 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 118.573 1.187 . . . . 10.0 107.871 175.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.8 m -65.72 157.76 5.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-O 122.721 1.248 . . . . 10.0 111.402 -174.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 33.6 tp -133.35 -44.09 0.84 Allowed 'General case' 0 CA--C 1.516 -0.363 0 C-N-CA 124.446 1.098 . . . . 10.0 110.015 177.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.633 HD11 HG21 ' A' ' 16' ' ' VAL . 0.3 OUTLIER -147.12 146.72 30.02 Favored 'General case' 0 C--O 1.24 0.585 0 N-CA-C 108.75 -0.833 . . . . 10.0 108.75 -162.343 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.416 ' HB2' ' HE2' ' A' ' 52' ' ' LYS . 32.6 tt0 -127.39 141.52 51.67 Favored 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 105.804 -1.924 . . . . 10.0 105.804 168.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.406 HD21 HD22 ' A' ' 66' ' ' LEU . 11.6 mt -130.04 143.13 50.62 Favored 'General case' 0 CA--C 1.518 -0.259 0 N-CA-C 107.749 -1.204 . . . . 10.0 107.749 -171.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.0 m -72.33 -7.76 51.32 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 126.347 1.859 . . . . 10.0 111.11 173.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 29.8 t30 -125.88 50.36 1.86 Allowed 'General case' 0 CA--C 1.558 1.269 0 C-N-CA 127.101 2.161 . . . . 10.0 110.733 173.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.586 ' OG ' HG21 ' A' ' 2' ' ' THR . 42.2 m -135.47 6.68 3.27 Favored 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 127.072 2.149 . . . . 10.0 112.665 164.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.96 -29.07 11.64 Favored 'General case' 0 CA--C 1.55 0.971 1 C-N-CA 133.122 4.569 . . . . 10.0 108.452 -150.063 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 . . . . . 0 C--O 1.245 0.857 0 C-N-CA 128.562 2.745 . . . . 10.0 110.648 124.854 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' BTN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_